Literature DB >> 11039321

A comparison of clinical, histopathological and cell-cycle markers in rats receiving the fungal toxins fumonisin B1 or fumonisin B2 by intraperitoneal injection.

G S Bondy1, M G Barker, G A Lombaert, C L Armstrong, S M Fernie, S Gurofsky, V Huzel, M E Savard, I H Curran.   

Abstract

Fumonisins B1 and B2 (FB1 and FB2) are fungal secondary metabolites produced by members of the genus Fusarium. Although FB1 is usually detected in greater quantities, FB2 frequently co-occurs in contaminated feeds and foods and contributes to the total toxin load. In the present study, the comparative toxicity of FB1 and FB2 was examined in male Sprague-Dawley rats administered toxin (0.75 mg/kg body weight) or vehicle control intraperitoneally (ip) for 2, 4 or 6 consecutive days. Clinical changes, including elevated serum cholesterol, alanine aminotransferase (ALT), creatinine and protein, were slightly more pronounced in FB1-treated rats. The most consistent hematological change was an increase in vacuolated bone marrow cells, which was more pronounced in FB1-treated rats. Histopathological changes were similar in FB1- and FB2-treated rats and included single cell necrosis in kidneys and liver, cytoplasmic vacuolation in adrenal cortex and lymphocytolysis in thymus. In the liver mRNA expression for the cyclin kinase inhibitor p21 gene was significantly increased in FB1- and FB2-treated rats, compared to controls. Expression of mRNA for the cyclin D1 gene was significantly depressed in FB2-treated rats. Hepatic cyclin E mRNA was elevated in response to FB1 and FB2 compared to controls. In FB2-treated animals this corresponded with decreased liver p27 mRNA expression. Hepatic proliferating cell nuclear antigen (PCNA) transcription was elevated in FB1- but not FB2- treated rats. Changes in liver microsomal protein levels of p27, cyclin E and PCNA were similar to changes in gene expression. In contrast, cyclin D1 protein levels were elevated in rats treated with FB1 and, to a lesser extent, FB2. The data indicate that FB1 and FB2 can alter the expression of genes associated with the cell cycle, and indicate a need for a further understanding of the mechanistic basis of FB1 and FB2 toxicity.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11039321     DOI: 10.1016/s0278-6915(00)00084-3

Source DB:  PubMed          Journal:  Food Chem Toxicol        ISSN: 0278-6915            Impact factor:   6.023


  6 in total

1.  Fumonisin and beauvericin induce apoptosis in turkey peripheral blood lymphocytes.

Authors:  Mary Ann Dombrink-Kurtzman
Journal:  Mycopathologia       Date:  2003       Impact factor: 2.574

2.  Screening toxicity study in young carp (Cyprinus carpio L.) on feed amended with fumonisin B1.

Authors:  Stjepan Pepeljnjak; Zdravko Petrinec; Sanja Kovacic; Maja Segvic
Journal:  Mycopathologia       Date:  2003       Impact factor: 2.574

3.  Dose and Exposure Time-Dependent Renal and Hepatic Effects of Intraperitoneally Administered Fumonisin B₁ in Rats.

Authors:  András Szabó; Judit Szabó-Fodor; Mariam Kachlek; Miklós Mézes; Krisztián Balogh; Róbert Glávits; Omeralfaroug Ali; Yarsmin Yunus Zeebone; Melinda Kovács
Journal:  Toxins (Basel)       Date:  2018-11-09       Impact factor: 4.546

4.  Stimulation of the proliferation of human normal esophageal epithelial cells by fumonisin B1 and its mechanism.

Authors:  Shao-Kang Wang; Ting-Ting Wang; Gui-Ling Huang; Ruo-Fu Shi; Li-Gang Yang; Gui-Ju Sun
Journal:  Exp Ther Med       Date:  2013-10-25       Impact factor: 2.447

5.  Sorafenib Treatment and Modulation of the Sphingolipid Pathway Affect Proliferation and Viability of Hepatocellular Carcinoma In Vitro.

Authors:  Katja Jakobi; Sandra Beyer; Alexander Koch; Dominique Thomas; Stephanie Schwalm; Stefan Zeuzem; Josef Pfeilschifter; Georgios Grammatikos
Journal:  Int J Mol Sci       Date:  2020-03-31       Impact factor: 5.923

Review 6.  Research Progress on Fumonisin B1 Contamination and Toxicity: A Review.

Authors:  Jia Chen; Jun Wen; Yating Tang; Jichao Shi; Guodong Mu; Rong Yan; Jing Cai; Miao Long
Journal:  Molecules       Date:  2021-08-29       Impact factor: 4.411

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.